A Digital Wellness Platform to help those with NAFLD with or without concurrent Metabolic Syndrome

Home About Our Approach Outcomes For Providers Wellness Program Packages and Services FAQs Contact

Our Outcomes

How Are We Unique?

We are laser focused on:

  • NAFLD and concurrent Metabolic Syndrome
  • Improving our member's wellness at the root cause, not just placing a band-aid on it
  • Medical Metrics 
    • FibroScans
    • Hemoglobin A1C
    • Triglycerides
    • LDL Cholesterol 
    • Medications for GERD, Diabetes, Hypertension and Hyperlipidemia
    • Changes in CPAP settings 
    • Quality of Life
  • Digital Monitoring/Machine Learning
  • Life Preservation-preventing premature death via disease reversal  

Our focus is NOT on aesthetics

Our Outcomes

NAFLD Improvement

FibroScan: a special ultrasound test that determines:

Steatosis (the amount of fat in the liver), shown as "S" score, range 0-3, 3 being severe

Fibrosis (scare tissue), shown as a F score, range 0-4, 4 being severe)

NAFLD Improvement

 Our member had a score of S3 and F0-1 prior to starting the NovoLiver program; four months later, she had a score of S0 and F0-1 meaning her liver fat had disappeared. 

 

NAFLD Improvement

Our member had a score of S3 and F2 prior to starting the NovoLiver program; nine months later, she had a score of S1 and F0-1 meaning her liver fat had decreased and scarring had improved significantly.

Average Weight Loss of a Member in the Program for Three Months or Longer:

10%

As of November 2022

Dempgraphics by NovoLiver

We're also tracking...

In addition to percentage body weight loss, we are tracking app utilization, support group attendance, changes in quality of life scores via a Short Form-12 (SF12), BMI, changes in anthropometric measurements [waist-to-hip, chest, triceps, quadriceps], changes in non-invasive testing parameters [imaging that captures steatosis & fibrosis levels, plus lab-based scoring systems like Hepatic Steatosis Index (HSI) and Fibrosis 4 Score (FIB-4)]. We are also tracking changes in medications for associated chronic conditions and mitigation of symptoms and signs of such conditions.

Proof of Concept Peer Reviewed Publications

  • White Paper AGA POWER-Practice Guide on Obesity and Weight Management, Education and Resources (click here to review article)
  • Establishing an Effective Weight Loss Program in a Community-Based Gastroenterology Practice: The Huron Gastro Experience (click here to review article)
  • Effective Treatment of Nonalcoholic Fatty Liver Disease using a Community-based Weight Management Program (click here to review article)
  • Improvement of Non-Alcoholic Fatty Liver Disease through a Comprehensive Weight Loss Program in a Community Gastroenterology Practice  (click here to review article)
  • Weight Loss Through Lifestyle Modifications Significantly Reduces Features of Nonalcoholic Steatohepatitis (click here to review article)